Valuation: NOVARTIS

Market Cap 267B 238B 222B 202B 380B 25,681B 383B 2,678B 1,042B 13,107B 1,001B 979B 42,131B P/E 2026 *
19.8x
P/E 2027 * 16.6x
Enterprise Value 298B 266B 248B 225B 425B 28,705B 428B 2,993B 1,165B 14,651B 1,119B 1,095B 47,092B EV / Sales 2026 *
5.17x
EV / Sales 2027 * 4.8x
Free-Float
91.66%
Yield 2026 *
3.09%
Yield 2027 * 3.23%
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Compliance Officer 58 14/04/2025
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Change 5-day change 1-year change 3-year change Capi.($)
+1.02%-2.48%+36.72%+113.37% 1,019B
-0.86%-6.57%+35.04%+61.70% 617B
+0.39%-0.82%+14.73%+79.11% 464B
-2.81%-5.74%+57.83%+35.28% 356B
+0.93%-1.83%+20.98%+41.43% 333B
+0.12%-4.05%+10.09%+33.53% 267B
-0.89%-5.83%-7.56%+7.91% 244B
+0.15%-3.76%+36.82%+51.81% 218B
-0.24%-5.14%+27.12%+93.28% 179B
Average -0.35%-3.54%+25.75%+57.49% 410.8B
Weighted average by Cap. -0.12%-3.54%+28.99%+69.12%

Financials

2026 *2027 *
Net sales 57.7B 51.47B 47.95B 43.64B 82.18B 5,557B 82.79B 579B 225B 2,836B 217B 212B 9,116B 61.42B 54.79B 51.05B 46.45B 87.48B 5,915B 88.13B 617B 240B 3,019B 231B 226B 9,704B
Net income 14.26B 12.72B 11.85B 10.78B 20.31B 1,373B 20.46B 143B 55.7B 701B 53.52B 52.36B 2,253B 15.8B 14.09B 13.13B 11.95B 22.5B 1,521B 22.67B 159B 61.72B 776B 59.3B 58.02B 2,496B
Net Debt 31.4B 28.01B 26.1B 23.75B 44.73B 3,024B 45.06B 315B 123B 1,544B 118B 115B 4,961B 28.22B 25.17B 23.45B 21.34B 40.19B 2,718B 40.49B 283B 110B 1,387B 106B 104B 4,459B
Logo NOVARTIS
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AAA